Gendon Iu Z
Vopr Virusol. 2002 Nov-Dec;47(6):4-11.
Recent achievements in development of influenza vaccines using long-term cell cultures MDSK or Vero are reviewed. Cell cultures were grown in bioreactors (fermenters) filled with microcarriers using serum-free culture media. Inactivated cultural influenza vaccines were clinically tested in many countries. The results of these trials showed that cultural influenza vaccines are as safe and immunogenic as conventional vaccines prepared using chicken embryos. It is emphasized that cultural influenza vaccines prepared using serum-free culture media have a number of advantages over embryonic influenza vaccines: standard preparation technology, intactness of all hemagglutinin antigen domains, absence of protein allergens and possible viral contamination inherent in chicken embryos and blood serum, and possibility of easy intensification of vaccine production in case of influenza pandemic. Taking into consideration these advantages, it may be suggested that cultural influenza vaccines will soon be widely used in medical practice.
综述了使用长期细胞培养物MDSK或Vero开发流感疫苗的最新成果。细胞培养物在装有微载体的生物反应器(发酵罐)中使用无血清培养基生长。灭活的细胞培养流感疫苗在许多国家进行了临床试验。这些试验结果表明,细胞培养流感疫苗与使用鸡胚制备的传统疫苗一样安全且具有免疫原性。需要强调的是,使用无血清培养基制备的细胞培养流感疫苗相对于胚胎流感疫苗具有许多优势:标准的制备技术、所有血凝素抗原结构域的完整性、不存在鸡胚和血清中固有的蛋白质过敏原及可能的病毒污染,以及在流感大流行时易于扩大疫苗生产的可能性。考虑到这些优势,可能会有人提出细胞培养流感疫苗将很快在医学实践中得到广泛应用。